Due to the correlation of miR‐16‐5p, miR‐34a‐5p, and miR‐‎‎335‐5p with TP53 and FOXO1 expression in RA PBMCs, they could be one of the ‎regulatory mechanisms and RA treatment targets. The gene discussed is TP53; the disease is rheumatoid arthritis.